Raclopride
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 3,5-dichloro-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-hydroxy-6-methoxybenzamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Half-life | 30 min |
| Identifiers | |
| CAS number | 84225-95-6  |
| ATC code | None |
| PubChem | CID 3033769 |
| IUPHAR ligand | 94 |
| ChemSpider | 2298373  |
| UNII | 430K3SOZ7G |
| ChEMBL | CHEMBL8809 |
| Chemical data | |
| Formula | C15H20Cl2N2O3 |
| Mol. mass | 347.236 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Raclopride is a synthetic compound that acts as an antagonist on D2 dopamine receptors.[1] It can be radiolabelled with the carbon-11 radioisotope and used in positron emission tomography (PET) scanning to assess the degree of dopamine binding to the D2 Dopamine receptor. For example, one study found decreasing binding with the personality trait detachment.[2]
[edit] References
- ^ C. Kohler, H. Hall, S. O. Ogren, L. Gawell (July 1985). "Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain". Biochemical Pharmacology 34 (13): 2251–2259. doi:10.1016/0006-2952(85)90778-6. PMID 4015674.
- ^ Lars Farde, J. Petter Gustavsson, Erik Jönsson (February 1997). "D2 dopamine receptors and personality traits". Nature 385 (6617): 590. doi:10.1038/385590a0. PMID 9024656.
[edit] External links
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
